Articles from Antidepressants

Primary tabs

Association Between Offspring ADHD Symptoms and Prenatal Benzodiazepines, Z-Hypnotics - Psychiatry Advisor

Submitted by Anonymous (not verified) on Fri, 04/05/2019 - 09:00

Association Between Offspring ADHD Symptoms and Prenatal Benzodiazepines, Z-Hypnotics  Psychiatry AdvisorInvestigators found no substantial increased risk for greater fine motor deficits or ADHD traits in offspring exposed to benzodiazepines or hypnotics at different ...

Khan: Foggy FDA guidance on genetic tests harms Americans - The Register-Guard

Submitted by Anonymous (not verified) on Fri, 04/05/2019 - 08:00

Khan: Foggy FDA guidance on genetic tests harms Americans  The Register-GuardFDA officials are sending mixed messages about a new genetic test they just approved — and the lack of clarity could jeopardize thousands of Americans' ...

Antidepressants are the new antipsychotics - News - McKnight's Long Term Care News - McKnight's Long Term Care News

Submitted by Anonymous (not verified) on Fri, 04/05/2019 - 06:00

Antidepressants are the new antipsychotics - News - McKnight's Long Term Care News  McKnight's Long Term Care NewsLong-term care providers have made remarkable progress in reducing antipsychotics. Now it's time to turn the attention to antidepressants.

Antidepressants are the new antipsychotics - Daily Editors' Notes - McKnight's Long Term Care News

Submitted by Anonymous (not verified) on Fri, 04/05/2019 - 06:00

Antidepressants are the new antipsychotics - Daily Editors' Notes  McKnight's Long Term Care NewsLong-term care providers have made remarkable progress in reducing antipsychotics. Now it's time to turn the attention to antidepressants.

Antidepressants Market Size Analysis and Forecast (2019-2025) | H Lundbeck, Astrazeneca, Eli Lilly and Company - Weekly Wall

Submitted by Anonymous (not verified) on Fri, 04/05/2019 - 03:42

Antidepressants Market Size Analysis and Forecast (2019-2025) | H Lundbeck, Astrazeneca, Eli Lilly and Company  Weekly WallThe report proves to be a highly useful resource for players to secure a strong position in the global Antidepressants market. With deep analysis about the ...

'Revolutionary' depression treatment brings hope to patients amid concerns about oversight - WLS-TV

Submitted by Anonymous (not verified) on Fri, 04/05/2019 - 02:18

'Revolutionary' depression treatment brings hope to patients amid concerns about oversight  WLS-TVKetamine has been hailed as a breakthrough treatment for depression and other disorders. But ketamine's history as an illicit, trippy party drug has some ...

Ketamine a Panacea for Resistant Depression? Not So Fast - Medscape

Submitted by Anonymous (not verified) on Thu, 04/04/2019 - 21:50

Ketamine a Panacea for Resistant Depression? Not So Fast  MedscapeReports of relapses and suicides are tempering some of the earlier excitement over ketamine's much-needed rapid relief for patients with severe depression.

School Shootings: A Root Cause Analysis (Hint: It’s Not the guns) - Santa Clarita Gazette

Submitted by Anonymous (not verified) on Thu, 04/04/2019 - 21:39

School Shootings: A Root Cause Analysis (Hint: It’s Not the guns)  Santa Clarita GazetteIf your engine broke down on your drive home from work this evening, would you immediately file a lawsuit against the gas station at which you last filled.

Methylphenidate in Childhood Predicts Later Antidepressant Use | Psychiatry & Behavioral Health Learning Network - Psych Congress Network

Submitted by Anonymous (not verified) on Thu, 04/04/2019 - 19:44

Methylphenidate in Childhood Predicts Later Antidepressant Use | Psychiatry & Behavioral Health Learning Network  Psych Congress NetworkChildren with high adherence to methylphenidate-based medications for the treatment of attention-deficit/hyperactivity disorder (ADHD) are significantly more ...

New Antidepressant Nasal Spray | Lifestyles | journalstar.com - Lincoln Journal Star

Submitted by Anonymous (not verified) on Thu, 04/04/2019 - 17:30

New Antidepressant Nasal Spray | Lifestyles | journalstar.com  Lincoln Journal StarThe Food and Drug Administration is expected to approve a new type of drug for depression.

Pages